Clinical Lab Chat

In this episode of Clinical Lab Chat, CLP’s Director of Business Intelligence, Chris Wolski, discusses the how and why of making precise clinical diagnosis of neurodegenerative diseases with Russ Lebovitz, MD, PhD, co-founder and CEO of Amprion.
 
Among the topics they discuss:
  • The critical importance of making accurate diagnoses of neurodegenerative diseases
  • Why alpha-synuclein is an accurate biomarker for a number of degenerative diseases, including Alzheimer’s
  • How adding neurodegenerative testing to the routine diagnostic menu would benefit patients and their caregivers
  • Why we’re entering a neurological healthcare “golden age”

What is Clinical Lab Chat?

Step into the world of clinical labs with a podcast that delves deep into both the science and the strategy. From groundbreaking diagnostic and molecular testing to the intricacies of lab management, our episodes offer a comprehensive look at the ever-evolving lab landscape. We bring you the latest in lab technology, innovative testing procedures, and key insights from industry decision-makers and influencers. Beyond the science, we also focus on the operational side of things, offering tips and trends in lab management, ensuring your lab runs efficiently and stays ahead of the curve. Whether you're deep into the world of clinical diagnostics or looking to enhance your lab's operational excellence, this podcast provides the insights you need to stay at the pinnacle of lab advancements.